INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE
Long-term mortality in patients with severe secondary mitral regurgitation and normal left ventricular ejection fraction: interventional perspective
EuroIntervention 2018;13:1881-1888 published online January 2018. DOI: 10.4244/EIJ-D-17-00561
Amr F. Barakat1, MD; Mohammad Q. Raza2, MD; Kinjal Banerjee2, MD; Rayji S. Tsutsui2, MD; Amgad Mentias1, MD; Karim Abdur Rehman1, MD; Badal Thakkar2, MD; Sajjad Gul1, MD; Raquib Faruqui2, MD; Amar Krishnaswamy2, MD; Leonardo L. Rodriguez2, MD; Richard Grimm2, DO; Brian Griffin2, MD; Emin Murat Tuzcu2, MD; Samir R. Kapadia2*, MD
1. Department of Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA; 2. Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, OH, USA
Aims: Patients with severe secondary mitral regurgitation (MR) and normal ejection fraction are being excluded from clinical trials evaluating transcatheter mitral devices. We sought to e
